Daily as of 3 Nov 16:00 ET
- Price
- below both $15.80 vs 50 $16.15 / 200 $16.16
- Projection
- 🟨Golden cross projected in 1 bar
- Test
- No active test
- Last cross
- 💀Death cross 24 Jun 2026 · projected 23 bars out
SMMT | Summit TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$15.80
+$1.00 (+6.76%)
Summit Therapeutics (SMMT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Jun 2026, but the two have been closing on each other and a golden cross is projected within 10 bars. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $16.03 vs 50 $16.39 / 200 $12.51
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $15.80 vs 50 $16.12 / 200 $15.13
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 21 Sep 2026 bar 2 · projected 21 bars out · tested 1 bar
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Sep 2026 | 🟨Golden | 4-hour | 21 bars out | 1 bar cross test |
| 24 Jun 2026 | 💀Death moderate | daily | 23 bars out | Not tested |
| 4 Jun 2026 | 💀Death | 4-hour | 8 bars out | Not tested |
| 27 May 2026 | 🟨Golden flat | daily | 19 bars out | 1 bar cross test |
| 9 Apr 2026 | 🟨Golden | 4-hour | 16 bars out | Not tested |
About SMMT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$83.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandlarge